US · Healthcare

Sino Biopharmaceutical Ltd ADR (SBHMY)

Biotechnology

Sino Biopharmaceutical Ltd ADR (SBHMY) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SBHMY

P/E ratio

25.00

Sino Biopharmaceutical Ltd ADR (SBHMY) — FAQ

What is SBHMY's P/E ratio?

The price-to-earnings (P/E) ratio for Sino Biopharmaceutical Ltd ADR (SBHMY) is 25.00 (data as of 2026-05-23).

Does Sino Biopharmaceutical Ltd ADR pay a dividend?

Dividend yield is not available in the current snapshot for Sino Biopharmaceutical Ltd ADR (SBHMY). Check the MyAverix Finance app for the latest dividend data.

What sector is Sino Biopharmaceutical Ltd ADR in?

Sino Biopharmaceutical Ltd ADR (SBHMY) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SBHMY listed on?

SBHMY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)